Abstract:Abstract Background Drug repurposing aims at finding new targets for already developed drugs. It becomes more relevant as the cost of discovering new drugs steadily increases. To find new potential targets for a drug, an abundance of methods and existing biomedical knowledge from different domains can be leveraged. Recently, knowledge graphs have emerged in the biomedical domain that integrate information about genes, drugs, diseases and other biological domains. Knowledge graphs can be used to predict new connections between compounds and diseases, leveraging the interconnected biomedical data around them. While real world use cases such as drug repurposing are only interested in one specific relation type, widely used knowledge graph embedding models simultaneously optimize over all relation types in the graph. This can lead the models to underfit the data that is most relevant for the desired relation type. For example, if we want to learn embeddings to predict links between compounds and diseases but almost the entirety of relations in the graph is incident to other pairs of entity types, then the resulting embeddings are likely not optimised to predict links between compounds and diseases. We propose a method that leverages domain knowledge in the form of metapaths and use them to filter two biomedical knowledge graphs (Hetionet and DRKG) for the purpose of improving performance on the prediction task of drug repurposing while simultaneously increasing computational efficiency. Results We find that our method reduces the number of entities by 60% on Hetionet and 26% on DRKG, while leading to an improvement in prediction performance of up to 40.8% on Hetionet and 14.2% on DRKG, with an average improvement of 20.6% on Hetionet and 8.9% on DRKG. Additionally, prioritization of antiviral compounds for SARS CoV-2 improves after task-driven filtering is applied. Conclusion Knowledge graphs contain facts that are counter productive for specific tasks, in our case drug repurposing. We also demonstrate that these facts can be removed, resulting in an improved performance in that task and a more efficient learning process.

Graph theory enables drug repurposing. How a mathematical model can drive the discovery of hidden Mechanisms of Action

Knowledge-driven drug repurposing using a comprehensive drug knowledge graph

Deep learning identifies explainable reasoning paths of mechanism of action for drug repurposing from multilayer biological network

Generating Drug Repurposing Hypotheses through the Combination of Disease-Specific Hypergraphs

Drug Repurposing using Consilience of Knowledge Graph Completion Methods

Explainable drug repurposing via path based knowledge graph completion

Relation-aware Heterogeneous Graph Transformer Based Drug Repurposing

A Multimodal Framework for Improving in Silico Drug Repositioning with the Prior Knowledge from Knowledge Graphs

A knowledge graph approach to drug repurposing for Alzheimer's, Parkinson's and Glioma using drug-disease-gene associations

Drug repurposing based on the DTD-GNN graph neural network: revealing the relationships among drugs, targets and diseases

Knowledge Graphs for drug repurposing: a review of databases and methods

A foundation model for clinician-centered drug repurposing

KGML-xDTD: a knowledge graph–based machine learning framework for drug treatment prediction and mechanism description

Drug Repurposing by Integrated Literature Mining and Drug-Gene-Disease Triangulation

Utilising Graph Machine Learning within Drug Discovery and Development

KG-Predict: A knowledge graph computational framework for drug repurposing

HGTDR: Advancing Drug Repurposing with Heterogeneous Graph Transformers

Design and application of a knowledge network for automatic prioritization of drug mechanisms

Uncovering hidden therapeutic indications through drug repurposing with graph neural networks and heterogeneous data

Task-driven knowledge graph filtering improves prioritizing drugs for repurposing